New drug approvals for 2020: Synthesis and clinical applications

被引：37
|
作者：
Yuan, Shuo [1 ,2 ]
Luo, Yong-Qiang [1 ,2 ]
Zuo, Jia-Hui [1 ,2 ]
Liu, Hui [1 ,2 ]
Li, Fang [1 ,2 ]
Yu, Bin [1 ,2 ]
机构：
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Key Lab Adv Drug Preparat Technol, Mil Educ, Zhengzhou 450001, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 215卷
基金：
中国国家自然科学基金;
关键词：
New drugs; Chemical synthesis; Clinical applications; FARNESYL-PROTEIN TRANSFERASE; PEPTIDE CGRP; OPEN-LABEL; PHASE-III; DISCOVERY; INHIBITORS; EFFICACY; POTENT; SELPERCATINIB; MULTICENTER;
D O I：
10.1016/j.ejmech.2021.113284
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
53 New drugs including 38 chemical entities and 15 biologics were approved by the U.S. Food and Drug Administration during 2020. Among the marketed drugs, 34 new small molecule drugs and 4 new diagnostic agents with privileged structures and novel clinical applications represent as promising leads for the development of new drugs with the similar indications and improved therapeutic efficacy. This review is mainly focused on the clinical applications and synthetic methods of 34 small-molecule drugs newly approved by the FDA in 2020. (c) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：34
相关论文
共 50 条
  • [1] New drug approvals for 2019: Synthesis and clinical applications
    Yuan, Shuo
    Yu, Bin
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 205
  • [2] New drug approvals for 2022: Synthesis and clinical applications
    Yuan, Shuo
    Shen, Dan-Dan
    Jia, Rui
    Sun, Ju-Shan
    Song, Jian
    Liu, Hong-Min
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (06) : 2352 - 2391
  • [3] New drug approvals for 2021: Synthesis and clinical applications
    Yuan, Shuo
    Wang, Dan-Shu
    Liu, Hui
    Zhang, Sheng-Nan
    Yang, Wei-Guang
    Lv, Meng
    Zhou, Yu-Xue
    Zhang, Sai-Yang
    Song, Jian
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 245
  • [4] New FDA drug approvals for 2024: Synthesis and clinical application
    Wang, Yingying
    Yang, Fuwei
    Wang, Baizhi
    Xie, Lijuan
    Chen, Wanying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285
  • [5] 2020 FDA drug approvals
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (02) : 85 - 90
  • [6] 2020 FDA drug approvals
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 85 - 90
  • [7] FDA new drug approvals in Q2 2020
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (08) : 503 - 503
  • [8] FDA new drug approvals in Q3 2020
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (11) : 746 - 746
  • [9] FDA new drug approvals in Q1 2020
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (05) : 299 - 299
  • [10] New FDA oncology small molecule drugs approvals in 2020: Mechanism of action and clinical applications
    Mendonca Nogueira, Thais Cristina
    Nora de Souza, Marcus Vinicius
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 46
12345